These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 639751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN, Miloushev AS.
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC, Trader MW, Dykes DJ, Laster WR, Schabel FM.
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [Abstract] [Full Text] [Related]

  • 5. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM, Erickson LC, Ringsdorf H, Zaharko DS.
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [Abstract] [Full Text] [Related]

  • 6. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD, Ganu UK, Gokhale SV.
    Indian J Physiol Pharmacol; 1989 Oct; 33(3):171-4. PubMed ID: 2592043
    [Abstract] [Full Text] [Related]

  • 7. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN, Milushev AS, Todorov DK.
    Neoplasma; 1980 Oct; 27(1):33-6. PubMed ID: 6892839
    [Abstract] [Full Text] [Related]

  • 8. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 9. Antileukemic synergism between cyclophosphamide and an antitumor platinum compound.
    Walker EM, Gale GR.
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):419-25. PubMed ID: 4750093
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL, Cruze PG.
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract] [Full Text] [Related]

  • 11. [Effectiveness of combined action of vitamins A, E and C and cyclophosphane or adriamycin on growth of transplanted tumors in mice].
    Mosienko VS, Khasanova LT, Sukolinskiĭ VN, Morozkina TS.
    Eksp Onkol; 1990 Sep; 12(3):55-7. PubMed ID: 2344827
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Sep; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 14. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV, Eremeeva AA, Tereshin IM.
    Antibiotiki; 1977 Sep; 22(2):153-8. PubMed ID: 404957
    [No Abstract] [Full Text] [Related]

  • 15. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH, Stablein DM, Wampler GL.
    Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
    [Abstract] [Full Text] [Related]

  • 16. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL, Kariev NI, Mainardi JV, Betancourt M, Lage A, Barroso MC, Alfonso L.
    Neoplasma; 1982 Sep; 29(1):65-71. PubMed ID: 7070556
    [Abstract] [Full Text] [Related]

  • 17. [Enhanced antitumor action of 5-fluorouracil when used in combination with 4-methylmercaptopyrazolo[3,4-d]pyrimidine 1-nucleoside].
    Lobova TG, Korbukh IA, Preobrazhenskaia MN, Garin AM.
    Eksp Onkol; 1988 Sep; 10(4):69-71. PubMed ID: 3181079
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT, Johnson RK, Kline I, Vadlamudi S, Gang M, Venditti JM, Goldin A.
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
    Glazman-Kuśnierczyk H, Matuszyk J, Radzikowski C.
    Immunopharmacol Immunotoxicol; 1992 Sep; 14(4):883-911. PubMed ID: 1294626
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.